At a glance
ClinicalIndex Comparison RecordN/ACompleted· 34 enrolled
Drug / intervention
Amber Glasses +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Glasses for Adolescent Delayed Sleep-Wake Phase Disorder (GLAD)
In Brief
A clinical study evaluating Amber Glasses and Clear Lens Glasses for Delayed Sleep-Wake Phase Disorder. Completed, enrolled 34 participants across 2 sites.
Detailed Summary
The purpose of this study is to determine if evening amber glasses combined with stable wake times will show an increase in total sleep time (TST) and an advance in sleep onset times (shift earlier) compared to the control group.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDelayed Sleep-Wake Phase Disorder
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartFeb 2019
First PostedMay 2020
Primary CompletionJun 2022
TodayJul 2026
First PostedMay 7, 2020
Enrollment StartFeb 27, 2019
Primary CompletionJun 3, 2022
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 6.2 years ago
Interventions
Amber Glassesdevice
Half of the participants will be wearing the amber glasses to see if they can help with sleep onset.
Clear Lens Glassesdevice
Half of the participants will be wearing the clear glasses to see if the glasses help with sleep onset.